financial or public health issues?


The Senegalese press has widely announced the celebrations of the 350th anniversary of the Merck Laboratory and the first anniversary of the CAMAD diamniadio on CICAD, which began on Diamniadio on 30 and 31 October, followed by the vaccine against cervical cancer, 9 first ladies, 12 in the presence of Minister of Health and Care. Senegalese political authorities in the middle of the pre-election campaign, of course, do not ignore the possibility of the prime minister and the head of state.

That is why we might think that this is a noble expression from the point of view of a public-private partnership, namely the stigmatization of women's infertility and the fight against non-communicable diseases, especially cancer. We are faced with a health initiative that seems to be the highest level of political commitment to fighting cervical cancer, the first gynecological cancer, which accounts for 34% of cases. cancer and 30% of deaths.

In addition, the Merck Oncology Fellowship Program, an ambitious program aimed at strengthening anti-cancer professional capacity and increasing the number of oncologists in Africa and the world, has been presented. evolve.

But in reality this was a gigantic and expensive commercial marketing campaign that was closed to the Expanded Immunization Program by introducing a vaccine against cervical cancer.

By highlighting this issue, not only for the honorable first ladies, with all due respect, to illustrate the conflicting power of the medical-pharmacy lobby that is in conflict with the vulnerability of those who have a duty to pursue a state-based policy based on logic that is quite strange to them.

Indeed, it is curious that the introduction of a vaccine that is subject to many controversies has not occurred after a national consensus following a wide-ranging debate, but by a fascinating, directly or indirectly sponsored summit, with the best personalities of our states.

In fact, despite the WHO approval, this vaccine provides only partial immunity as it only acts as a preventive measure against HPVs 6, 11, 16, 18, which is certainly the most common (About 75%). There may be a number of side effects (cancerous cancer lesions, autoimmune diseases …) that were temporarily suspended in some countries (Spain) or the recommendation of health authorities in other countries has ceased. (Japan).

Regrettably, some objections raised by some of the experts (Pr Celestino Rodrigues Pereira) or public figures (Bruno D & # 39; Erneville) have been abolished by the communication tools of several first African women's cabinets, under the supervision of marketing tenors, from the Merck Foundation.

Understand it! It is not about rejecting the introduction of a preventive vaccine against cervical cancer, but they are sorry that they do not take into account the concerns of users of health services and programs. , by creating a frank, open debate, without a taboo.

This has led us to believe that there is an urgent need to strengthen the intervention of civil society on health issues, which too often have the sole political authority and health professional have their own policy, whether personal, purely technical or academic.

Involvement of civil society actors can not only serve strategies developed by technical and financial partners that ignore socio-cultural realities or pharmaceutical-pharmaceutical companies that promote immediate gains that hinder the real progress of the social and health well-being of the population .

Dr. Mohamed Lamine LY, member of COSAS


Source link